Clinical trial / 2014
Nigella sativa supplementation improved LDL cholesterol, blood glucose, and menopausal symptoms in perimenopausal women.
An open-label crossover study evaluated 69 perimenopausal women given 1600 mg/day of encapsulated pure powdered Nigella sativa or placebo for 12 weeks, followed by a 14-day washout and crossover. In both cycles, Nigella sativa treatment led to significant improvements in low-density lipoprotein cholesterol and blood glucose (P<0.05). It also induced a significant reduction in the prevalence and severity of menopausal symptoms and improved some quality-of-life components (P<0.05), while total cholesterol, HDL, and triglycerides showed no significant differences between groups.
- Study type
- Open-label crossover study
- Who was studied
- 69 perimenopausal women aged 45 to 65 in Rawang, Malaysia
- What was measured
- Metabolic profile (LDL-C, blood glucose, lipids), anthropometrics, blood pressure, hormonal levels, and menopausal symptoms/quality of life
THE PAPER
Alternative supplement for enhancement of reproductive health and metabolic profile among perimenopausal women: a novel role of Nigella sativa.
Latiff LA, Parhizkar S, Dollah MA, Hassan ST. Iran J Basic Med Sci, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.